A detailed history of Salvus Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Salvus Wealth Management, LLC holds 3,064 shares of NVO stock, worth $267,701. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,064
Previous 2,866 6.91%
Holding current value
$267,701
Previous $409,000 11.0%
% of portfolio
0.23%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$119.07 - $145.42 $23,575 - $28,793
198 Added 6.91%
3,064 $364,000
Q2 2024

Jul 16, 2024

BUY
$122.71 - $146.91 $26,996 - $32,320
220 Added 8.31%
2,866 $409,000
Q1 2024

Apr 12, 2024

BUY
$102.11 - $135.92 $42,477 - $56,542
416 Added 18.65%
2,646 $339,000
Q4 2023

Jan 08, 2024

BUY
$87.78 - $105.45 $195,749 - $235,153
2,230 New
2,230 $230,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Salvus Wealth Management, LLC Portfolio

Follow Salvus Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salvus Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salvus Wealth Management, LLC with notifications on news.